Biofrontera AG Sponsored ADR EPS Growth (diluted)

EPS Growth (diluted) of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (diluted) growth rates and interactive chart. Year over year growth in diluted earnings per share.


Highlights and Quick Summary

  • EPS Growth (diluted) for the quarter ending June 30, 2022 was -87.64% (a -78.58% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (diluted) decreased by -713.3%
  • Annual EPS Growth (diluted) for 2021 was 90.59% (a -63.37% decrease from previous year)
  • Annual EPS Growth (diluted) for 2021 was 247.28% (a -305.06% decrease from previous year)
  • Annual EPS Growth (diluted) for 2020 was -120.59% (a -527.32% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (diluted) of Biofrontera AG Sponsored ADR

Most recent EPS Growth (diluted)of BFAGY including historical data for past 10 years.

Interactive Chart of EPS Growth (diluted) of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -87.64% -409.09%
2021 4378.54% 14.29% 0.0% 29.03% 90.59%
2020 78.01% 52.54% 100.0% -34.78% -120.59%
2019 62.57% -210.53% 41.67% -95.76%
2018 25.81% -95.02%
2017 -167.14% 67.8% -119.24%
2016 -71.43% -123.03%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic